Coagulation | CHOP Research Institute
 

Coagulation

Margaritis Laboratory

Margaritis Lab

The Margaritis Lab uses basic biochemical, molecular, and complex in vivo methodology within the field of coagulation to advance the understanding of molecular mechanisms involved in pro- and anti-coagulant reactions and conduct translational research for the treatment of coagulation defects.

Samelson-Jones Laboratory

Samelson-Jones Lab

Our lab is interested in the hemostasis system, especially coagulation factor VIII and IX, which are deficient in the bleeding disorders hemophilia A and B. By studying these blood proteins, the lab team aims to improve therapies for children with these diseases including gene therapy.

Benjamin J. Samelson-Jones, MD, PhD
Benjamin J. Samelson-Jones

Dr. Samelson-Jones is a pediatric hematologist dedicated to improving the lives of children with bleeding and clotting disorders. His research focuses on gene therapy for hemophilia, the biochemical basis of coagulation, and the immune responses to hemophilia therapies.

E-mail:
samelsonjonesb [at] chop.edu
Paris Margaritis, DPhil
Paris Margaritis

Dr. Margaritis uses biochemical, molecular, and complex in vivo methodology within the field of coagulation to advance the understanding of molecular mechanisms involved in pro- and anti-coagulant reactions, and translate research for the treatment of coagulation defects.

E-mail:
margaritis [at] chop.edu

CHOP Thrombosis Expert's Work to Be Honored

Published on
Jun 3, 2015
in Cornerstone Blog
The International Society on Thrombosis and Haemostasis will honor The Children’s Hospital of Philadelphia’s Sriram Krishnaswamy, PhD, at its annual meeting.

Award Will Support Novel Hemophilia Therapy Investigation

Published on
Aug 22, 2014
in Cornerstone Blog
The Children’s Hospital of Philadelphia’s Lacramioara Ivanciu, PhD, was one of five investigators who recently received funding through the Bayer Hemophilia Awards Program (BHAP).